These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32798558)
1. Dexmedetomidine alleviates non-ventilation associated lung injury via modulating immunology phenotypes of macrophages. Shen Q; Xu G; Liu J; Wang L; Zhou Y; Yu Y; Lv C; Liu X Life Sci; 2020 Oct; 259():118249. PubMed ID: 32798558 [TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway. Xue BB; Chen BH; Tang YN; Weng CW; Lin LN Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750 [TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway. Chen H; Sun X; Yang X; Hou Y; Yu X; Wang Y; Wu J; Liu D; Wang H; Yu J; Yi W Bosn J Basic Med Sci; 2018 May; 18(2):162-169. PubMed ID: 29510084 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine reduces ventilator-induced lung injury via ERK1/2 pathway activation. Zhu CH; Yu J; Wang BQ; Nie Y; Wang L; Shan SQ Mol Med Rep; 2020 Dec; 22(6):5378-5384. PubMed ID: 33173983 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling. Liu J; Huang X; Hu S; He H; Meng Z Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263 [TBL] [Abstract][Full Text] [Related]
6. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031 [TBL] [Abstract][Full Text] [Related]
7. Effect of dexmedetomidine on lung ischemia‑reperfusion injury. Jiang L; Li L; Shen J; Qi Z; Guo L Mol Med Rep; 2014 Feb; 9(2):419-26. PubMed ID: 24345905 [TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway. Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804 [TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling. Chi X; Wei X; Gao W; Guan J; Yu X; Wang Y; Li X; Cai J J Transl Med; 2015 Jun; 13():190. PubMed ID: 26070954 [TBL] [Abstract][Full Text] [Related]
10. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway. Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine reduces IL-4 and IgE expression through downregulation of theTLR4/NF-κB signaling pathway to alleviate airway hyperresponsiveness in OVA mice. Zhi J; Duan Q; Wang QY; Du X; Yang D Pulm Pharmacol Ther; 2022 Aug; 75():102147. PubMed ID: 35863724 [TBL] [Abstract][Full Text] [Related]
12. [The impacts of regulating Toll-like receptor 2/nuclear factor-ΚB signal pathway on rats with ventilator-induced lung injury]. Fu R; Pan L; Lin F; Ge W; Huang C; Dai H Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Dec; 26(12):865-9. PubMed ID: 25476077 [TBL] [Abstract][Full Text] [Related]
13. [Effects of Dexmedetomidine on the levels of proinflammatory mediators IL-1βand TNF-α in pulmonary ischemia/reperfusion injury rats and the mechanisms]. Xiang BQ; He JB; Gao H; Luo ZY; Dai YY; Wang WT Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):415-419. PubMed ID: 29926585 [TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine alleviates airway hyperresponsiveness and allergic airway inflammation through the TLR4/NF‑κB signaling pathway in mice. Xiao S; Wang Q; Gao H; Zhao X; Zhi J; Yang D Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014685 [TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway. Liang S; Wang Y; Liu Y Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody against Toll-like receptor 4 attenuates ventilator-induced lung injury in rats by inhibiting MyD88- and NF-κB-dependent signaling. Huang C; Pan L; Lin F; Dai H; Fu R Int J Mol Med; 2017 Mar; 39(3):693-700. PubMed ID: 28204830 [TBL] [Abstract][Full Text] [Related]
17. The effect of dexmedetomidine on inflammatory response of septic rats. Zhang J; Wang Z; Wang Y; Zhou G; Li H BMC Anesthesiol; 2015 May; 15():68. PubMed ID: 25929655 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine Ameliorates Post-CPB Lung Injury in Rats by Activating the PI3K/Akt Pathway. Li J; Dou X; Li D; He M; Han M; Zhang H J Invest Surg; 2020 Jul; 33(6):576-583. PubMed ID: 30913929 [No Abstract] [Full Text] [Related]
19. Dexmedetomidine attenuates ventilator-induced lung injury in rats by up-regulating NLRC3. Zhang B; Zhang X; Li Q; Ma F; Sun L; Wang M Ann Palliat Med; 2020 Sep; 9(5):2474-2484. PubMed ID: 32787359 [TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway. Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]